Brief: Biocartis Detects Omicron Variant With Idylla™ SARS-CoV-2 Testing
09/12/2021 06:05
Dec 9 (Reuters) - BIOCARTIS GROUP NV BCART.BR :
* REG-PRESS RELEASE BIOCARTIS GROUP NV: BIOCARTIS’ IDYLLA™
SARS-COV-2 TESTING SUCCESSFULLY DETECTS OMICRON VARIANT
Source text for Eikon: ID:nGNE2w1gdt
Further company coverage: BCART.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Biocartis NV
See all newsBrief: Biocartis Group NV Appoints Randy Polonsky As Chief Financial Officer
Brief: Biocartis Appoints New Chief Business Officer, VP Global Marketing
Brief: Biocartis And Merck To Collaborate
Brief: Biocartis's Secured Creditors Enforced Their Security Over Subsidiaries Shares
Brief: Biocartis Announces Expansion Of Its Collaboration With Apis Assay Technologies